MARSHALL WACE, LLP - INTELLIA THERAPEUTICS INC ownership

INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 65 filers reported holding INTELLIA THERAPEUTICS INC in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
MARSHALL WACE, LLP ownership history of INTELLIA THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$13,574,792
+3178.9%
389,074
+5157.8%
0.03%
+3000.0%
Q3 2022$414,000
-21.0%
7,400
-26.9%
0.00%0.0%
Q2 2022$524,000
-93.2%
10,124
-90.5%
0.00%
-93.3%
Q1 2022$7,726,000
-36.2%
106,316
+42.2%
0.02%
-72.7%
Q2 2021$12,101,000
+910.9%
74,744
+401.3%
0.06%
+1000.0%
Q1 2021$1,197,000
+63.3%
14,909
+10.7%
0.01%
+25.0%
Q4 2020$733,000
+200.4%
13,466
+18.0%
0.00%
+100.0%
Q2 2016$244,00011,4080.00%
Other shareholders
INTELLIA THERAPEUTICS INC shareholders Q3 2016
NameSharesValueWeighting ↓
Atlas Venture Associates IX, LLC 1,113,376$89,359,00015.01%
Burrage Capital Management LLC 63,634$5,107,0004.14%
Integral Health Asset Management, LLC 170,000$13,643,0003.90%
Ally Bridge Group (NY) LLC 225,000$18,057,0003.46%
Elmwood Wealth Management, Inc. 67,174$5,391,0003.29%
Nikko Asset Management Americas, Inc. 4,843,270$388,697,0001.90%
ARK Investment Management 9,611,911$771,404,0001.53%
Spectrum Planning & Advisory Services Inc. 18,521$1,486,0001.53%
Lombard Odier Asset Management (Switzerland) SA 282,953$22,708,0001.51%
Intellectus Partners, LLC 71,625$4,606,0001.26%
View complete list of INTELLIA THERAPEUTICS INC shareholders